AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 >>
Results: 1-25/100
Gene therapy in the treatment of human cancer
Authors: Gomez-Navarro, J Bilbao, G Curiel, DT
Citation: J. Gomez-navarro et al., Gene therapy in the treatment of human cancer, MOLECULAR BASIS OF HUMAN CANCER, 2002, pp. 541-565
An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression
Authors: Hemminki, A Belousova, N Zinn, KR Liu, B Wang, MH Chaudhuri, TR Rogers, BE Buchsbaum, DJ Siegal, GP Barnes, MN Gomez-Navarro, J Curiel, DT Alvarez, RD
Citation: A. Hemminki et al., An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression, MOL THER, 4(3), 2001, pp. 223-231
Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers
Authors: Yamamoto, M Alemany, R Adachi, Y Grizzle, WE Curiel, DT
Citation: M. Yamamoto et al., Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers, MOL THER, 3(3), 2001, pp. 385-394
Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors
Authors: Garcia-Castro, J Segovia, JC Garcia-Sanchez, F Lillo, R Gomez-Navarro, J Curiel, DT Bueren, JA
Citation: J. Garcia-castro et al., Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors, MOL THER, 3(1), 2001, pp. 70-77
Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo
Authors: Reynolds, PN Nicklin, SA Kaliberova, L Boatman, BG Grizzle, WE Balyasnikova, IV Baker, AH Danilov, SM Curiel, DT
Citation: Pn. Reynolds et al., Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo, NAT BIOTECH, 19(9), 2001, pp. 838-842
Gene therapy for the treatment of cancer
Authors: Buchsbaum, DJ Curiel, DT
Citation: Dj. Buchsbaum et Dt. Curiel, Gene therapy for the treatment of cancer, CANC BIO R, 16(4), 2001, pp. 275-288
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
Authors: Zou, WP Machelon, V Coulomb-L'Hermin, A Borvak, J Nome, F Isaeva, T Wei, S Krzysiek, R Durand-Gasselin, I Gordon, A Pustilnik, T Curiel, DT Galanaud, P Capron, F Emilie, D Curiel, TJ
Citation: Wp. Zou et al., Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells, NAT MED, 7(12), 2001, pp. 1339-1346
Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications
Authors: Casado, E Gomez-Navarro, J Yamamoto, M Adachi, Y Coolidge, CJ Arafat, WO Barker, SD Wang, MH Mahasreshti, PJ Hemminki, A Gonzalez-Baron, M Barnes, MN Pustilnik, TB Siegal, GP Alvarez, RD Curiel, DT
Citation: E. Casado et al., Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications, CLIN CANC R, 7(8), 2001, pp. 2496-2504
Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma
Authors: Mahasreshti, PJ Navarro, JG Kataram, M Wang, MH Carey, D Siegal, GP Barnes, MN Nettelbeck, DM Alvarez, RD Hemminki, A Curiel, DT
Citation: Pj. Mahasreshti et al., Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma, CLIN CANC R, 7(7), 2001, pp. 2057-2066
Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids
Authors: Grill, J Van Beusechem, VW Van de Valk, P Dirven, CMF Leonhart, A Pherai, DS Haisma, HJ Pinedo, HM Curiel, DT Gerritsen, WR
Citation: J. Grill et al., Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids, CLIN CANC R, 7(3), 2001, pp. 641-650
A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency
Authors: Suzuki, K Fueyo, J Krasnykh, V Reynolds, PN Curiel, DT Alemany, R
Citation: K. Suzuki et al., A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency, CLIN CANC R, 7(1), 2001, pp. 120-126
Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus
Authors: Zhang, HG Wang, YM Xie, JF Liang, X Hsu, HC Zhang, X Douglas, J Curiel, DT Mountz, JD
Citation: Hg. Zhang et al., Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus, GENE THER, 8(9), 2001, pp. 704-712
CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors
Authors: Alemany, R Curiel, DT
Citation: R. Alemany et Dt. Curiel, CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors, GENE THER, 8(17), 2001, pp. 1347-1353
A novel system for mitigation of ectopic transgene expression induced by adenoviral vectors
Authors: Reynolds, PN Holmes, MD Adachi, Y Kaliberova, L Curiel, DT
Citation: Pn. Reynolds et al., A novel system for mitigation of ectopic transgene expression induced by adenoviral vectors, GENE THER, 8(16), 2001, pp. 1271-1275
Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors
Authors: Wesseling, JG Bosma, PJ Krasnykh, V Kashentseva, EA Blackwell, JL Reynolds, PN Li, H Parameshwar, M Vickers, SM Jaffee, EM Huibregtse, K Curiel, DT Dmitriev, I
Citation: Jg. Wesseling et al., Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors, GENE THER, 8(13), 2001, pp. 969-976
Selective gene delivery toward gastric and esophageal adenocarcinoma cellsvia EpCAM-targeted adenoviral vectors
Authors: Heideman, DAM Snijders, PJF Craanen, ME Bloemena, E Meijer, CJLM Meuwissen, SGM van Beusechem, VW Pinedo, HM Curiel, DT Haisma, HJ Gerritsen, WR
Citation: Dam. Heideman et al., Selective gene delivery toward gastric and esophageal adenocarcinoma cellsvia EpCAM-targeted adenoviral vectors, CANC GENE T, 8(5), 2001, pp. 342-351
Efficient gene transduction by RGD-fiber modified recombinant adenovirus into dendritic cells
Authors: Asada-Mikami, R Heike, Y Kanai, S Azuma, M Shirakawa, K Takaue, Y Krasnykh, V Curiel, DT Terada, M Abe, T Wakasugi, H
Citation: R. Asada-mikami et al., Efficient gene transduction by RGD-fiber modified recombinant adenovirus into dendritic cells, JPN J CANC, 92(3), 2001, pp. 321-327
Analysis of cell-specific promoters for viral gene therapy targeted at thevascular endothelium
Authors: Nicklin, SA Reynolds, PN Brosnan, MJ White, SJ Curiel, DT Dominiczak, AF Baker, AH
Citation: Sa. Nicklin et al., Analysis of cell-specific promoters for viral gene therapy targeted at thevascular endothelium, HYPERTENSIO, 38(1), 2001, pp. 65-70
Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix
Authors: Huh, WK Gomez-Navarro, J Arafat, WO Xiang, JL Marameshwar, PJ Alvarez, RD Barnes, MN Curiel, DT
Citation: Wk. Huh et al., Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix, GYNECOL ONC, 83(2), 2001, pp. 370-377
Transcriptional targeting for ovarian cancer gene therapy
Authors: Casado, E Nettelbeck, DM Gomez-Navarro, J Hemminki, A Baron, MG Siegal, GP Barnes, MN Alvarez, RD Curiel, DT
Citation: E. Casado et al., Transcriptional targeting for ovarian cancer gene therapy, GYNECOL ONC, 82(2), 2001, pp. 229-237
An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites
Authors: Barker, SD Casado, E Gomez-Navarro, J Xiang, J Arafat, W Mahasreshti, P Pustilnik, TB Hemminki, A Siegal, GP Alvarez, RD Curiel, DT
Citation: Sd. Barker et al., An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites, GYNECOL ONC, 82(1), 2001, pp. 57-63
Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene
Authors: Contreras, JL Bilbao, G Smyth, CA Jiang, XL Eckhoff, DE Jenkins, SM Thomas, FT Curiel, DT Thomas, JM
Citation: Jl. Contreras et al., Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptotic Bcl-2 gene, TRANSPLANT, 71(8), 2001, pp. 1015-1023
Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement
Authors: Contreras, JL Bilbao, G Smyth, C Eckhoff, DE Xiang, XL Jenkins, S Cartner, S Curiel, DT Thomas, FT Thomas, JM
Citation: Jl. Contreras et al., Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement, SURGERY, 130(2), 2001, pp. 166-174
Viral cancer therapy
Authors: Suzuki, K Curiel, DT
Citation: K. Suzuki et Dt. Curiel, Viral cancer therapy, REV INV CLI, 53(4), 2001, pp. 346-356
Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin
Authors: Krasnykh, V Belousova, N Korokhov, N Mikheeva, G Curiel, DT
Citation: V. Krasnykh et al., Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin, J VIROLOGY, 75(9), 2001, pp. 4176-4183
Risultati: 1-25 | 26-50 | 51-75 | 76-100 >>